Cook the lentils in boiling water for 10 minutes, skim off any scum then simmer for a further 15 minutes. Meanwhile finely chop the onion, mushrooms and walnuts.
Drain the lentils, then when cooled combine with all the other ingredients in a mixing bowl. Use your hands to mix the ingredients together.
Lightly grease a baking tray with a little butter. Form the mixture into four evenly sized cakes using a pastry cutter or similar device and place them on the greased pan. Cook at 380 degrees for 25-30 minutes.
Please avoid the snap peas, carrots, and sweet potatoes pictured above as they are not recommended in the initial stage of the program. Instead enjoy with a garden salad!
There is new hope in the ever-growing battle of obesity in our nation. The FDA has recently approved two new weight lose drugs. This has been the first time in 13 years that new drugs have been approved for use. Qsymia (pronounced kyoo-sim-EE-uh) was developed by Vivus of Mountain View, California. The other drug Belviq (BEL-VEEK) from Arena Pharmaceutical was the second approved drug. Both drugs are set to come out in the fourth quarter, which could be as early as October of 2012.
Qsymia is a combination of two existing drugs, phetermine and topiratmate. Phentermine is the safer half of the once popular fen-phen drug. Currently it is successfully being used as an appetite suppressant at many weight loss clinics. Phetermine is thought to trigger the release of the brain chemical called norepinephrine. It also increases the blood concentration of the appetite-regulating hormone leptin. The other part of the new drug, Topiramate, is a seizure/migraine drug that can increase the feeling of fullness, makes food taste less appealing, and increases calorie burning.
Belviq causes weight loss by activating the serotonin 2C receptors in the brain. Activating these sensors can help patients eat less and feel more full. Both drugs are meant to be used on a temporary basis to help patients jump-start their weight loss program.
Both Qsymia and Belviq have been approved for use for obese people (BMI of 30 or above) and over weight people (BMI 27 or higher) who, also exhibit at least one weight related medical condition such as: hypertension, type 2 diabetes, or high cholesterol. In clinical trials, Qsymia and Belviq worked best when combined with a low calorie diet and exercise. Last year, Vivus funded a study that found that patients using Qsymia lost an average of 22 lbs a year. Seventy percent of Qsymia users lost at least 5% of their body weight compare to only twenty percent of the placebo group. Belviq exhibited similar results enabling 47% of the users to lose 5% of their total body weight over the year.
Qsymia and Belviq are only available by prescription and will only be available from certified pharmacies and medical weight loss clinics. Complete Clinics, of Chicago, Illinois, is one weight loss clinic that is very excited to offer these new drugs. Leveraging a long history of expertise and experience in helping patients utilize FDA approved medications to assist with weight loss, the medical professionals at Complete Clinics are determined to provide the help and support you need to select the weight loss aids that will best suit your needs and your conditions. There is no magic cure all pill and each drug is best combined with a healthy diet and exercise.